Relative oral efficacy and acute toxicity of hydroxypyridin-4-one iron chelators in mice [see comments]
Authors:
Open Access
- 1 December 1990
- journal article
- Published by American Society of Hematology in Blood
- Vol. 76 (11) , 2389-2396
Abstract
The relationship between the oral efficacy and the acute toxicity of hydroxypyridin-4-one iron chelators has been investigated to clarify structure-function relationships of these compounds in vivo and to identify compounds with the maximum therapeutic safety margin. By comparing 59Fe excretion following oral or intraperitoneal administration of increasing doses of each chelator to iron-overloaded mice, the most effective compounds have been identified. These have partition coefficients (Kpart) above 0.3 in the iron-free form with a trend of increasing oral efficacy with increasing Kpart values (r = .6). However, this is achieved at a cost of increasing acute toxicity, as shown by a linear correlation between 59Fe excretion increase per unit dose and 1/LD50 (r = .83). A sharp increase in the LD50 values is observed for compounds with Kpart values above 1.0, suggesting that such compounds are unlikely to possess a sufficient therapeutic safety margin. Below a Kpart of 1.0, acute toxicity is relatively independent of lipid solubility. All the compounds are less toxic by the oral route than by the intraperitoneal route, although iron excretion is not significantly different by these two routes. At least five compounds (CP51, CP94, CP93, CP96, and CP21) are more effective orally than the same dose of intraperitoneal desferrioxamine (DFO) (P less than or equal to .02) or orally administered L1(CP20) (P less than or equal to .02).Keywords
This publication has 10 references indexed in Scilit:
- ANIMAL TOXICOLOGY OF IRON CHELATOR L1The Lancet, 1989
- Selection of Hydroxypyridin-4-Ones for the Treatment of Iron Overload Using In Vitro and In Vivo ModelsHemoglobin, 1988
- 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE, AN ORALLY ACTIVE CHELATOR FOR TREATMENT OF IRON OVERLOADThe Lancet, 1987
- Iron chelation studies using desferrioxamine and the potential oral chelator, 1,2-dimethyl-3-hydroxypyrid-4-one, in normal and iron loaded rats.Journal of Clinical Pathology, 1987
- In vivo Evaluation of Hydroxypyridone Iron Chelators in a Mouse ModelActa Haematologica, 1987
- Evaluation in vivo of hydroxypyrid-4-one iron chelators intended for the treatment of iron overload by the oral routeBiochemical Society Transactions, 1986
- Interaction of transferrin with iron‐loaded rat peritoneal macrophagesBritish Journal of Haematology, 1986
- Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeabilityJournal of Medicinal Chemistry, 1980
- Mechanism of Desferrioxamine‐Induced Iron Excretion in ThalassaemiaBritish Journal of Haematology, 1979
- Lipid Solubility and Drug Penetration of the Blood Brain BarrierExperimental Biology and Medicine, 1974